Incidence and management of hepatic venoocclusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT)

MeSH terms

• Adult
• Aged
• Diagnosis, Differential
• Disease-Free Survival
• Female
• Fibrinolytic Agents / administration & dosage*
• Graft vs Host Disease / diagnosis
• Graft vs Host Disease / drug therapy*
• Graft vs Host Disease / etiology*
• Graft vs Host Disease / mortality
• Hematologic Neoplasms / complications
• Hematologic Neoplasms / mortality
• Hematologic Neoplasms / therapy
• Hematopoietic Stem Cell Transplantation*
• Humans
• Incidence
• Liver Diseases / diagnosis
• Liver Diseases / drug therapy*
• Liver Diseases / etiology*
• Liver Diseases / mortality
• Male
• Middle Aged
• Polydeoxyribonucleotides / administration & dosage*
• Time Factors
• Transplantation Conditioning / adverse effects*
• Transplantation, Autologous
• Transplantation, Homologous
• Vascular Diseases / diagnosis
• Vascular Diseases / drug therapy*
• Vascular Diseases / etiology*
• Vascular Diseases / mortality